Patent 7223772 was granted and assigned to Smithkline Beecham Limited on May, 2007 by the United States Patent and Trademark Office.
The invention provides the compounds of formula (I)and pharmaceutically acceptable derivatives thereof wherein:R0 and R1 are independently selected from the group consisting of H, halogen, C1-6alkyl, C1-6alkoxy, and C1-6alkoxy substituted by one or more fluorine atoms;R2 is selected from the group consisting of H, C1-6alkyl, C1-6alkyl substituted by one or more fluorine atoms, C1-6alkoxy, C1-6hydroxyalkyl, SC1-6alkyl, C(O)H, C(O)C1-6alkyl, C1-6alkylsulphonyl, and C1-6alkoxy substituted by one or more fluorine atoms; andR3 is C1-6alkyl or NH2.